To Study the Prevalence of Insomnia in Geriatric COPD Patients Who Are Enrolled in a Pulmonary Rehabilitation Program.

This study has been completed.

Sponsored by:	Hackensack University Medical Center
Information provided by:	Hackensack University Medical Center
ClinicalTrials.gov Identifier:	NCT00346554

Purpose

The goal for COPD patients in pulmonary rehabilitation programs is to improve the quality of life. COPD is known to be worse at night as are other respiratory problems such as CHF. Saturation is known to get worse nocturnally as well. Furthermore, these COPD rehabilitation patients tend to be older and increasing age is associated with an increase in the incidence of sleep disorders. We suspect that there is an increase in the incidence of sleep disorders in COPD patients. We plan to further study these patients using questionnaires. A preliminary study was done, but the results were not comparable to national statistics. We plan to repeat the study, only changing the questions to a format comparable to data from the National Sleep Foundation.

Condition
COPD Sleep Disorders

MedlinePlus related topics: Rehabilitation Sleep Disorders

U.S. FDA Resources

Study Type:	Observational
Study Design:	Cohort, Prospective
Official Title:	To Study the Prevalence of Insomnia in Geriatric COPD Patients Who Are Enrolled in a Pulmonary Rehabilitation Program.

Further study details as provided by Hackensack University Medical Center:

Biospecimen Retention: None Retained

Biospecimen Description:

Enrollment:	50
Study Start Date:	April 2006
Study Completion Date:	May 2008
Primary Completion Date:	May 2008 (Final data collection date for primary outcome measure)

Show Detailed Description

Eligibility

Ages Eligible for Study:	60 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No
Sampling Method:	Non-Probability Sample

Study Population

Greitric COPD patients who are enrolled in Pulmonary Rehabilitation at HUMC

Criteria

Inclusion Criteria:

COPD
rehabilitation program
FEV1<60%

Exclusion Criteria:

FEV1>60%

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00346554

Locations

United States, New Jersey
Hackensack University Medical Center - Pulmonary Rehabilitation
Hackensack, New Jersey, United States, 07601

Sponsors and Collaborators

Hackensack University Medical Center

Investigators

Principal Investigator:	Hormoz Ashtyani, MD	Hackensack University Medical Center
Principal Investigator:	Susan Zafarlotfi, Ph.D	Hackensack University Medical Center

More Information

Responsible Party:	Hackensack University Medical Center ( Hormoz Ashtyani M.D. )
Study ID Numbers:	06.01.008
Study First Received:	June 28, 2006
Last Updated:	October 21, 2008
ClinicalTrials.gov Identifier:	NCT00346554
Health Authority:	United States: Institutional Review Board

Keywords provided by Hackensack University Medical Center:

COPD
Sleep disorders
pulmonary rehabilitation

Study placed in the following topic categories:

Signs and Symptoms
Lung Diseases, Obstructive
Respiratory Tract Diseases
Mental Disorders

Lung Diseases
Neurologic Manifestations
Sleep Disorders
Pulmonary Disease, Chronic Obstructive

Additional relevant MeSH terms:

Nervous System Diseases

ClinicalTrials.gov processed this record on January 14, 2009